Latest News

11 May 2020

Directors’ Choice Series Launches at TRI

A brand new series that will provide you with insights from current and past journal editors
More about Directors’ Choice Series Launches at TRI
5 May 2020

Growth hormone boosts liver surgery success

TRI-based researchers discover Growth Hormone plays an important role in increasing the success of liver surgery.
More about Growth hormone boosts liver surgery success
30 April 2020

New ovarian and pancreatic cancer treatment

Professor Hooper has developed a biomolecule which he hopes to begin trialling in patients with ovarian and pancreatic cancer.
More about New ovarian and pancreatic cancer treatment
28 April 2020

Promising new drug for acute myeloid leukaemia

A new drug in clinical trials has the potential to improve the survival rate of patients with acute myeloid leukaemia.
More about Promising new drug for acute myeloid leukaemia
21 April 2020

Melanoma revealing its secrets

Professor Nikolas Haass and his team are unlocking the secrets of melanoma cells to identify better treatments for the cancer.
More about Melanoma revealing its secrets
16 April 2020

New drug to beat chemo resistance in ovarian cancer

In a preclinical study, researchers find low doses of a drug can overcome chemotherapy resistance in an ovarian cancer sub-type
More about New drug to beat chemo resistance in ovarian cancer

Pages

Events

19 July 2024 11:00 AM1:00 PM

TRI Seminar Series: Cancer

Come along to the second instalment of the TRI Seminar Series for 2024, focusing on Cancer Metabolism.
More about TRI Seminar Series: Cancer
26 July 2024 12:30 PM2:30 PM

Special Ethical Bystander Training – Males only

Ethical bystanders play an essential role in nurturing a safe and respectful workplace with a zero-tolerance to violence. This Special Ethical Bystander Training session is targeted towards males as they have been underrepresented at past Ethical Bystander Training at TRI and UQ.
More about Special Ethical Bystander Training – Males only